Similar Search Results

Price caps versus reimbursement limits : pharmaceutical regulation under market integration through parallel trade

Birg, Laura - 2019 - Revised Version March 2019

manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …

Persistent link: https://www.econbiz.de/10011986314

Effects of price cap regulation on the pharmaceutical supply chain

Chen, Xu; Yang, Huan; Wang, Xiaojun - In: Journal of business research : JBR 97 (2019), pp. 281-290

Persistent link: https://www.econbiz.de/10012002965

Advertising regulations in pharmaceutical markets : product versus enlightenment

Ishida, Junichiro; Takahara, Tsuyoshi - 2019

This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the … of the content regulation is ambiguous and depends, among other things, on the cost effectiveness of advertisement and …

Persistent link: https://www.econbiz.de/10012024745

Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? : evidence from parity laws

Nathenson, Robert; Richards, Michael R. - In: International journal of health economics and management 18 (2018) 3, pp. 321-336

Persistent link: https://www.econbiz.de/10012025924

Deadly alchemists : implications of the illicit pharmaceutical industry in China for human and health security

Teo, Victor; Yoon, Sungwon - In: Illicit industries and China's shadow economy : …, (pp. 78-103). 2019

Persistent link: https://www.econbiz.de/10011966008

Economics of the pharmaceutical industry

Lakdawalla, Darius - In: Journal of economic literature 56 (2018) 2, pp. 397-449

Persistent link: https://www.econbiz.de/10011941652

The impact of physician-level drug budgets on prescribing behavior

Blankart, Katharina; Koch, Taika; Kostev, Karel; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 213-222

Persistent link: https://www.econbiz.de/10011946212

Parallel imports and manufacturer rebates : evidence from Germany

Birg, Laura - 2019

In this paper, I study the effect of a change in the mandatory manufacturer rebate on wholesale prices for pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel imports in a two-country model. An increase in the...

Persistent link: https://www.econbiz.de/10011949028

Competition, regulation, and entry timing in marketing for pharmaceutical line extensions

Kina, Samuel H. - 2011

Persistent link: https://www.econbiz.de/10011949716

Is self-regulation sufficient? : case of the German transparency code

Buske, Kristin; Jentzsch, Stefan J.; Bechter, Clemens - In: Administrative Sciences : open access journal 6 (2016) 1/3, pp. 1-12

The German pharmaceutical industry is stepping ahead with its implementation of a new transparency disclosure code for cooperation between pharmaceutical companies and health care professionals (HCPs) and health care organisations (HCOs). In Germany, this transparency code ("Transparenzkodex")...

Persistent link: https://www.econbiz.de/10012015756